The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Hinaben Dhruve
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Hinaben Dhruve, a non-promoter acquirer, acquired 2,50,000 equity shares (1.34%) of Integrated Proteins Ltd on August 7, 2025, through the conversion of her existing warrants via preferential allotment. Prior to this, she held 2,50,000 warrants (1.34% on a diluted basis) with no voting shares; post-conversion, she holds 1.34% of the voting capital. The company's total equity share capital expanded sharply from 32,03,600 shares (Rs. 3.20 crore) to 1,87,13,600 shares (Rs. 18.71 crore), a roughly 5.8x increase. The acquirer's proportional stake remains unchanged since she was already entitled to these shares via warrants. This is a disclosure under SEBI's Takeover Regulations (Reg 29(2)) for exercise/conversion of instruments.
Existing shareholders face significant equity dilution (share count up nearly six-fold), which will reduce earnings per share proportionally. The acquirer's own stake percentage does not change, and since she is a non-promoter holding only 1.34%, this is unlikely to materially affect control or trigger near-term takeover concerns.